Literature DB >> 19854054

Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma.

Rebecca M Steele1, Francesca Benedini, Stefano Biondi, Valentina Borghi, Laura Carzaniga, Francesco Impagnatiello, Daniela Miglietta, Wesley K M Chong, Ranjan Rajapakse, Alessandro Cecchi, Claudia Temperini, Claudiu T Supuran.   

Abstract

Novel bi-functional compounds with a nitric oxide (NO)-releasing moiety bound to a dorzolamide scaffold were investigated. Several compounds were synthesized and their activity as selective carbonic anhydrase inhibitors (CAI) evaluated in vitro on recombinant hCA type I, II and IV enzyme isoforms where they showed different degrees of potency and selectivity to hCA II. A high resolution X-ray crystal structure for the CA II adduct with 8 confirmed the high affinity of this class of compounds for the enzyme. Compounds 4, 6, and 8 showed highly potent and efficacious NO-mediated properties as assessed by their vascular relaxant effect on methoxamine-precontracted rabbit aortic rings. Finally, compounds 4 and 6 exerted potent intraocular pressure (IOP) lowering effects in vivo in normotensive rabbits thereby anticipating their potential for the treatment of hypertensive glaucoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854054     DOI: 10.1016/j.bmcl.2009.10.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.

Authors:  Fabrizio Carta; Mayank Aggarwal; Alfonso Maresca; Andrea Scozzafava; Robert McKenna; Emanuela Masini; Claudiu T Supuran
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

2.  Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations.

Authors:  Jason Wagner; Balendu Sankara Avvaru; Arthur H Robbins; Andrea Scozzafava; Claudiu T Supuran; Robert McKenna
Journal:  Bioorg Med Chem       Date:  2010-06-15       Impact factor: 3.641

Review 3.  Discovery of novel inhibitors for the treatment of glaucoma.

Authors:  Kishore Cholkar; Hoang M Trinh; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Discov       Date:  2015-01-09       Impact factor: 6.098

4.  gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension.

Authors:  Marco Blangetti; Barbara Rolando; Elisabetta Marini; Konstantin Chegaev; Stefano Guglielmo; Loretta Lazzarato; Laura Lucarini; Emanuela Masini; Roberta Fruttero
Journal:  ACS Med Chem Lett       Date:  2017-09-13       Impact factor: 4.345

Review 5.  The vital role for nitric oxide in intraocular pressure homeostasis.

Authors:  Ester Reina-Torres; Michael L De Ieso; Louis R Pasquale; Michael Madekurozwa; Joseph van Batenburg-Sherwood; Darryl R Overby; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2020-11-28       Impact factor: 21.198

6.  Parallel screening of wild-type and drug-resistant targets for anti-resistance neuraminidase inhibitors.

Authors:  Kai-Cheng Hsu; Hui-Chen Hung; Jim-Tong Horng; Ming-Yu Fang; Chun-Yu Chang; Ling-Ting Li; I-Jung Chen; Yun-Chu Chen; Ding-Li Chou; Chun-Wei Chang; Hsing-Pang Hsieh; Jinn-Moon Yang; John T-A Hsu
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

7.  A class of carbonic anhydrase I - selective activators.

Authors:  Erol Licsandru; Muhammet Tanc; Istvan Kocsis; Mihail Barboiu; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2016-11-01       Impact factor: 5.051

Review 8.  Nitric oxide donors and selective carbonic anhydrase inhibitors: a dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis.

Authors:  Simone Carradori; Adriano Mollica; Celeste De Monte; Arianna Ganese; Claudiu T Supuran
Journal:  Molecules       Date:  2015-03-31       Impact factor: 4.411

9.  Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma.

Authors:  Laura Lucarini; Lucia Magnelli; Nicola Schiavone; Alfonso Crisci; Alessio Innocenti; Luca Puccetti; Fabio Cianchi; Sara Peri; Claudiu T Supuran; Laura Papucci; Emanuela Masini
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 10.  The Application of Nitric Oxide for Ocular Hypertension Treatment.

Authors:  Binze Han; Maomao Song; Liping Li; Xinghuai Sun; Yuan Lei
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.